Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

The AdaptDx from MacuLogix Inc. has the potential to be the first practical diagnostic instrument for early detection of AMD. Akin to routine peripheral vision testing for glaucoma, the noninvasive desktop device measures impaired dark adaptation (the speed with which vision is recovered when moving from a brightly lit environment to darkness), an early-stage marker of AMD development.

The AdaptDx from MacuLogix Inc. has the potential to be the first practical diagnostic instrument for early detection of AMD. Akin to routine peripheral vision testing for glaucoma, the noninvasive desktop device measures impaired dark adaptation (the speed with which vision is recovered when moving from a brightly lit environment to darkness), an early-stage marker of AMD development.